Hemp-derived products containing CBD – the non-intoxicating cannabinoid President Donald Trump proposed covering via Medicare last month – would be regulated under federal law for the first time if a bipartisan bill introduced in Congress on Thursday passes.
The U.S. Food and Drug Administration (FDA) would set cannabinoid limits for hemp-derived products under the Hemp Enforcement, Modernization and Protection (HEMP) Act, sponsored by Republican U.S. Rep. Morgan Griffith of West Virginia and Texas Democratic U.S. Rep. Marc Veasey.
ADVERTISEMENT
The bill does not regulate cannabis.
While draft language appears to empower the health secretary to set THC limits, the bill’s intent is limited to CBD, according to a statement from Griffith’s office.
That’s still good news for the U.S. hemp sector, which
Read full article on Marijuana Business Daily
